BamSEC and AlphaSense Join Forces
Learn More

Esperion Therapeutics Inc.

NASDAQ: ESPR    
Share price (1/7/25): $2.17    
Market cap (1/7/25): $428 million

Transcripts

CY 2024
CY 2023
CY 2022
CY 2021
CY 2020
Other Revised 11/18/20 Esperion Therapeutics, Inc. Presents at Jefferies 2020 Virtual London Healthcare Conference, Nov-18-2020 02:40 PM 11/18/20 Other Revised 11/17/20 Esperion Therapeutics, Inc. Presents at 2020 Stifel Virtual Healthcare Conference, Nov-17-2020 08:40 AM 11/17/20 Other Revised 11/09/20 Esperion Therapeutics, Inc. Presents at 29th Annual Virtual Healthcare Conference, Nov-09-2020 02:00 PM 11/09/20 Earnings Revised 06/01/23 Esperion Therapeutics, Inc., Q3 2020 Earnings Call, Nov 02, 2020 11/02/20 Other Revised 09/14/20 Esperion Therapeutics, Inc. Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-14-2020 03:45 PM 09/14/20 Earnings Revised 06/01/23 Esperion Therapeutics, Inc., Q2 2020 Earnings Call, Aug 10, 2020 08/10/20 Other Revised 06/01/23 Esperion Therapeutics, Inc. Presents at Goldman Sachs 41st Annual Global Healthcare Conference, Jun-11-2020 01:40 PM 06/11/20 Other Revised 05/28/20 Esperion Therapeutics, Inc. - Shareholder/Analyst Call 05/28/20 Other Revised 05/12/20 Esperion Therapeutics, Inc. Presents at BofA Securities 2020 Health Care Conference, May-12-2020 09:00 AM 05/12/20 Earnings Revised 05/06/20 Esperion Therapeutics, Inc., Q1 2020 Earnings Call, May 06, 2020 05/06/20 Other Revised 02/27/20 Esperion Therapeutics, Inc. - Special Call 02/27/20 Other Revised 06/01/23 Esperion Therapeutics, Inc. - Special Call 02/24/20 Other Revised 01/15/20 Esperion Therapeutics, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 through Jan-16-2020 01/15/20
CY 2019
CY 2018
CY 2017
CY 2016
CY 2015